Skip to main content
Log in

Induction of matrix metalloproteinases MMP-1 and MMP-2 by co-culture of breast cancer cells and bone marrow fibroblasts

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Two invasive breast cancer cell lines (MDA-MB-231 and BT-549) were found to be more adherent and have greater migratory capacity on bone marrow fibroblasts than three non-invasive cell lines (MCF-7, T47D and BT-483). Antibodies to the adhesion molecules CD44, E-cadherin, ICAM-1, and integrin chains α2, α3, α4, α5, α6, αv, α1, α3 and α7 failed to inhibit breast cancer cell migration through bone marrow fibroblasts. Inhibitors of matrix metalloproteases, 1, 10-phenanthroline, Ro-9790, TIMP-1 and TIMP-2 were able to attenuate the migration of MDA-MB-231 cells through bone marrow fibroblast monolayers suggesting a role for these enzymes in the migration of breast cancer cells through bone marrow adherent layers. Co-culture of MDA-MB-231 cells and bone marrow fibroblasts resulted in augmentation of the levels of the matrix metalloproteases MMP-1 and MMP-2 in culture supernatants. Soluble factors produced by bone marrow fibroblasts were responsible for the increase in MMP-1 levels. However, maximal MMP-2 production was dependent on direct contract between the breast cancer cells and the bone marrow fibroblasts. Modulation of MMP production by cell–cell contact or soluble factors suggests a mechanism by which breast cancer cells can enhance their ability to invade the bone marrow microenvironment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Honig S: Treatment of metastatic disease: Hormonal therapy and chemotherapy. In: Harris J, Lippman M, Morrow M, and Hellman S, (eds) Diseases of the Breast, Lippincott-Raven Publishers, Philadelphia, 1996, pp 669–734

    Google Scholar 

  2. Peters W: Treatment of metastatic disease: High-dose chemotherapy for breast cancer. In: Harris J, Lippman M, Morrow M, and Hellman S, (eds) Diseases of the Breast. Lippincott-Raven Publishers, Philadelphia, 1996, pp 735–743

    Google Scholar 

  3. Ross A, Cooper B, Lazarus H, Mackay W, Moss T, Ciobanu N, Tallman M, Kennedy M, Davidson N, Sweet D, Winter C, Akard L, Jansen J, Copelan E, Meagher R, Herzig R, Klumpp T, Kahn D, Warner N: Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques Blood 82: 2605–2610, 1993

    Google Scholar 

  4. Kohn E, Liotta L: Molecular insights into cancer invasion: Strategies for prevention and intervention. Cancer Res 55: 1856–1862, 1995

    Google Scholar 

  5. Stetler-Stevenson W, Aznavoorian S, Liotta L: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Ann Rev Cell Biol 9: 541–573, 1993

    Google Scholar 

  6. Inoue T, Yashiro M, Nishimura S, Maeda K, Sawada T, Ogawa Y, Sowa M, Hirakawa-YS, Chung K: Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer. Int J Mol Med 4: 73–77, 1999

    Google Scholar 

  7. Sutinen M, Kainulainen T, Hurskainen T, Vesterlund E, Alexander JP, Overall CM, Sorsa T, Salo T: Expression of matrix metalloproteinases (MMP-1 and-2) and their inhibitors (TIMP-1,-2 and-3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Br J Cancer 77: 2239–2245, 1998

    Google Scholar 

  8. Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH: Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 149: 273–282, 1996

    Google Scholar 

  9. Aust G, Hofmann A, Laue S, Rost A, Kohler T, Scherbaum W: Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messanger-RNA and protein. Thyroid 7: 713–724, 1997

    Google Scholar 

  10. Aho S, Rouda S, Kennedy SH, Qin H, Tan EM: Regulation of human interstitial collagenase (matrix metalloproteinase-1) promotor activity by fibroblast growth factor. Eur J Biochem 247: 503–510, 1997

    Google Scholar 

  11. Nutt J, Lunec J: Induction of metalloproteinase (MMP1) expression by epidermal growth factor (EGF) receptor stimulation and serum deprivation in human breast tumour cells. Eur J Cancer 32A: 2127–2135, 1996

    Google Scholar 

  12. Brenneisen P, Wlaschek M, Wenk J, Blaudschun R, Hinrichs R, Dissemond J, Krieg T, Scharffetter-Kochanek K: Ultraviolet-B induction of interstitial collagenase and stromelyin-1 occurs in human dermal fibroblasts via an autocrine interleukin-6-dependent loop. FEBS Lett 449: 36–40, 1999

    Google Scholar 

  13. Rao V, Singh R, Delimont D, Finnell R, Bridge J, Neff J, Garvin B, Pickering D, Sanger W, Buehler B, Schaefer G: Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha. Int J Oncol 14: 291–300, 1999

    Google Scholar 

  14. Piedagnel R, Murphy G, Ronco P, Lelongt B: Matrix metalloproteinase 2 (MMP2) and MMP9 are produced by kidney collecting duct principal cells but are differentially regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor. J Biol Chem 274: 1614–1620, 1999

    Google Scholar 

  15. Kubota S, Ito H, Ishibashi Y, Seyama Y: Anti-α3 integrin antibody induces the activated form of matrix metalloprotease-2 (MMP-2) with concomitant stimulation of invasion through matrigel by human rhabdomyosarcoma cells. Int J Cancer 70: 106–111, 1997

    Google Scholar 

  16. Kortlepel K, Bendall L, Gottlieb D: Adhesion molecule expression on human myeloid leukemic cells: Regulation by growth factors. Leukemia 7: 1174–1179, 1993

    Google Scholar 

  17. Bendall LJ, Kortlepel K, Gottlieb DJ: Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of beta 1 and beta 2 integrin mechanisms. Blood 82: 3125–3132, 1993

    Google Scholar 

  18. Gu B, Bendall LJ, Wiley JS: Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases. Blood 92: 946–951, 1998

    Google Scholar 

  19. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239–3245, 1987

    Google Scholar 

  20. Clarke R: Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice Induction of MMP-1 and MMP-2 by co-culture 115 and the characteristics of several tumorigenic cell lines. Breast Cancer Res Treat 39: 69–86, 1996

    Google Scholar 

  21. Bae SN, Arand G, Azzam H, Pavasant P, Torri J, Frandsen TL, Thompson EW: Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigelbased in vitro assays. Breast Cancer Res Treat 24: 241–255, 1993

    Google Scholar 

  22. Eccles S, Box G, Court W, Bone E, Thomas W, Brown P: Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). Cancer Res 56: 2815–2822, 1996

    Google Scholar 

  23. Yoneda T, Sasaki A, Dunstan C, Williams P, Bauss F, De Clerck Y, Mundy G: Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. Clin Invest 99: 2509–2517, 1997

    Google Scholar 

  24. Singer C, Marbaix E, Lemoine P, Courtoy P, Eeckhout Y: Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts. Eur J Biochem 259: 40–45, 1999

    Google Scholar 

  25. HIoyhtyIa M, Fridman R, Komarek D, Porter-Jordan K, Stetler-Stevenson W, Liotta L, Liang C: Immunohistochemical localisation of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies. Int J Cancer 56: 500–505, 1994

    Google Scholar 

  26. Noel A, Hajitou A, L'Hoir C, Maquoi E, Baramova E, Lewalle JM, Remacle A, Kebers F, Brown P, Calberg-Bacq CM, Foidart JM: Inhibition of stromal matrix metalloproteases: effects on breast-tumor promotion by fibroblasts. Int J Cancer 76: 267–273, 1998

    Google Scholar 

  27. Long L, Navab R, Brodt P: Regulation of the Mr 72,000 type IV collagenase by the type I insulin-like growth factor receptor. Cancer Res 58: 3243–3247, 1998

    Google Scholar 

  28. Kobayashi T, Hattori S, Nagai Y, Tajima S, Nishikawa T: Differential regulation of MMP-2 and MMP-9 gelatinases in cultured human keratinocytes. Dermatology 197: 1–5, 1998

    Google Scholar 

  29. Wingrove C, Garr E, Godsland I, Stevenson J: 17 betaoestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells. Biochim Biophys Acta 1406: 169–174, 1998

    Google Scholar 

  30. Xie B, Laouar A, Huberman E: Autocrine regulation of macrophage differentiation and 92-kDa gelatinase production by tumor necrosis factor-alpha via alpha5 beta1 integrin in HL-60 cells. J Biol Chem 273: 11583–11588, 1998

    Google Scholar 

  31. Esteve P, Tremblay P, Houde M, St-Pierre Y, Mandeville R: In vitro expression of MMP-2 and MMP-9 in glioma cells following exposure to inflammatory mediators. Biochim Biophys Acta 1403: 85–96, 1998

    Google Scholar 

  32. Kusano K, Miyaura C, Inada M, Tamura T, Ito A, Nagase H, Kamoi K, Suda T: Regulation of matrix metalloproteinases (MMP-2,-3,-9, and-13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology 139: 1338–1345, 1998

    Google Scholar 

  33. Boyd RS, Balkwill FR: MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts. Br J Cancer 80: 315–321, 1999

    Google Scholar 

  34. Brooks P, Stromblad S, Sanders L, von Schalscha T, Aimes R, Stetler-Stevenson W, Quigley J, DA C: Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85: 683–693, 1996

    Google Scholar 

  35. Ellerbroek S, Fishman D, Kearns A, Bafetti L, Stack M: Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through betal integrin. Cancer Res 59: 1635–1641, 1999

    Google Scholar 

  36. Guo H, Majmudar G, Jensen TC, Biswas C, Toole BP, Gordon MK: Characterization of the gene for human Emmprin, a tumor cell surface inducer of matrix metalloproteinases. Gene 220: 99–108, 1998

    Google Scholar 

  37. Pishvaian MJ, Feltes CM, Thompson P, Bussemakers MJ, Schalken JA, Byers SW: Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res 59: 947–952, 1999

    Google Scholar 

  38. Hazan RB, Kang L, Whooley BP, Borgen PI: N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun 4: 399–411, 1997

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saad, S., Bendall, L.J., James, A. et al. Induction of matrix metalloproteinases MMP-1 and MMP-2 by co-culture of breast cancer cells and bone marrow fibroblasts. Breast Cancer Res Treat 63, 105–115 (2000). https://doi.org/10.1023/A:1006437530169

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006437530169

Navigation